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Abstracts / International Journal of Surgery 12 (2014) S13eS117 S101treatment. Rural patients travelled a statistically signiﬁcant larger distance
compared with urban patients in an elective setting (p<0.001). Emergency
patients presented at a signiﬁcantly older age compared to elective pa-
tients (p¼0.004).
Conclusions: a one stop UGI cancer clinic could reduce travel distance for
rural patients, potentially improving care and patient satisfaction.
0998: POSITRON EMISSION TOMOGRAPHY IN OESOPHAGEAL CANCER
STAGING: A TAILORED APPROACH
David Bunting *, Wesley Lai, Grant Sanders. Derriford Hospital, Plymouth,
UK.
Introduction: The authors aim to re-evaluate the role of PET-CT in the
staging of oesophageal cancer (OC). They investigate whether it is possible
to identify a group of patients on the basis of endoscopy and CT ﬁndings
that can safely be spared from this investigation.
Methods: Consecutive patients undergoing PET-CT scan for the staging of
localised OC diagnosed between 2010 and 2013 were identiﬁed from a
specialist MDT database. Without knowledge of the PET-CT result, patients
were stratiﬁed into low-risk or high-risk groups according to the likeli-
hood of identifying metastatic disease on PET-CT based on speciﬁed CT/
endoscopy criteria.
Results: In 385 undergoing PET-CT, metastatic disease was identiﬁed in
52(13.5%) patients. All 52 patients had been correctly stratiﬁed as high-risk
according to the criteria. 112 patients were stratiﬁed as low-risk and 273 as
high-risk. Mean time from diagnosis surgery was 68.6 days which
compared to 49.6 days in a separate group of patients not undergoing PET-
CT (p¼0.04).
Conclusions: In one of the largest studies to date, the authors have
introduced a new classiﬁcation that can accurately stratify patients ac-
cording to the risk of having metastatic disease. This could be used to avoid
unnecessary PET-CT in 33% of patients.
1048: STAGING LAPAROSCOPY IN OESOPHAGO-GASTRIC CANCER: A
TAILORED APPROACH
David Bunting *, Wesley Lai, Andrei Tanase, Grant Sanders. Derriford
Hospital, Plymouth, UK.
Introduction: The authors aim to re-evaluate the role of staging laparos-
copy (SL) in the management of oesophago-gastric cancer and investigate
whether it is possible to identify a group of patients on the basis of
endoscopy and CT ﬁndings that will not beneﬁt and can be spared from
this investigation.
Methods: Consecutive patients undergoing SL in the work-up of localised
oesophago-gastric cancer between 2010 and 2013 were identiﬁed from a
specialist MDT database. Without knowledge of the SL result, patients
were stratiﬁed into low-risk or high-risk groups according to the likeli-
hood of operability based on speciﬁc endoscopy/CT criteria.
Results: Of 193 patients undergoing SL, 28(15%) were found to have
inoperable disease at SL. All 28 cases identiﬁed at SL had been correctly
stratiﬁed as high-risk. 42 patients were predicted as low risk and 151 as
high risk. None of the low risk patients went on to have inoperable disease
at SL or laparotomy.
Conclusions: A proposed classiﬁcation based on initial endoscopy and CT
ﬁndings is able to identify a group of patients at low risk of having
inoperable disease. This group, representing 25% of the cases subse-
quently deemed resectable on SL could have safely been spared the
procedure.
1202: BIODEGRADABLE OESOPHAGEAL STENTS IN THE MANAGEMENT
OF BENIGN AND MALIGNANT OESOPHAGEAL STRICTURES
Stephen McCain *, Scott McCain, Barry Quinn, Ronan Gray, Paul Rice.
Craigavon Area Hospital, Craigavon, UK.
Introduction: Biodegradable oesophageal stents are used in the man-
agement of refractory benign oesophageal strictures and malignant stric-
tures which may proceed to surgery. Our aimwas to review the safety and
efﬁcacy of biodegradable oesophageal stents in the management of benign
and malignant strictures.
Methods: Patients were identiﬁed using hospital coding data and radi-
ology PACS. Charts and hospital databases were retrospectively reviewed.
Data collected included patient demographics and outcomes. Dysphagia
was graded using the Mellow and Pinkas dysphagia grading scale.Results: Stents were deployed successfully in 29 of 30 attempts. 17 stents
were inserted for benign and 12 for malignant disease. Pre and post pro-
cedure swallowing scores were recorded for 27 procedures and resulted in
a mean improvement (2.88-1.15 p<0.002). One patient experienced tran-
sient chest pain. No serious complications occurred. There was no mor-
tality at 30 days. 3 patients progressed to oesophagectomy with no
anastomotic leaks in this group. 4 patients required repeat biodegradable
stenting (mean 273 days). 5 patients with malignancy proceeded to metal
stent insertion (mean 51 days).
Conclusions: Biodegradable stent insertion is a safe and efﬁcacious
method of treating oesophageal strictures, limiting repeat intervention in
benign disease and allowing nutrition during staging of malignancy. There
were no increased surgical complications at oesophagectomy.
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0108: CORRELATION OF CLINICAL DIAGNOSIS VS URODYNAMIC DIAG-
NOSIS IN THE MANAGEMENT OF URINARY INCONTINENCE
Binu M.K. Thomas 1,*, Siobhan Woolsey 2. 1Causeway Hospital, Coleraine, UK;
2Belfast City Hospital, Belfast, UK.
Introduction: The need for Urodynamics in the diagnosis of lower urinary
tract has been a topic fordebate for a long time. Even though it has improved
the knowledge of the pathophysiology of lower urinary tract dysfunction,
many are still reluctant to use this. The opinions for and against routine use
of Urodynamics varies among clinicians. In our studywe aim to evaluate the
usefulness of urodynamics in the management of urinary incontinence.
Method: 100 patients who underwent Urodynamics were selected and
Urodynamic diagnoses were compared with their clinical diagnosis based
on their symptoms to determine if there was any correlation between the
two.
Results: Of the 100 patients, 66 complained of urge incontinence and of
these, 35 were found to have detrusor over activity on Urodynamics. The
remaining 31 did not have urodynamically demonstrated urge inconti-
nence. 4 Patients who complained of urge incontinence were actually
found to have urodynamically proven stress incontinence. Among the 34
who did not complain of urge incontinence, 3 were found to have uro-
dynamically proven detrusor over activity (8.8%).
Conclusions: The well known saying of Blaivas - ' bladder is an unreliable
witness ' still hold true and Urodynamic study was found to play a vital role
in the assessment of lower urinary tract dysfunction.
0116: THE MANAGEMENT OF URETERIC STONES IN THE EMERGENCY
DEPARTMENT
Kirsty Dawson *, Tharani Nitkunan, Nasr Arsanious, Lindsay Dawson.
Croydon University Hospital, London, UK.
Introduction: To develop a proforma detailing speciﬁc criteria regarding
which patients with ureteric stones require admission and which patients
can be safely discharged. Therefore, limiting unnecessary bed days and
improving patient safety.
Methods: Data was collected prospectively for patients over 18 years, with
image proven ureteric stones at Croydon University Hospital over 2 month
periods; initially September-October 2012 and again August-September
2013, following the introduction of the proforma in December 2012. Pa-
rameters reviewed included patient epidemiological factors, imaging,
observations, blood results and patient outcome (i.e. whether the patient
had been admitted or discharged). The outcomes for patients were
deemed appropriate or inappropriate using the British Association of
Urological Surgeons (BAUS) guidelines.
Results: In the initial study, 28 patients met the inclusion criteria, of these,
22 patients (78.6%) had appropriate outcomes and 6 patients (21.4%) had
inappropriate outcomes. In the repeat study following the implementation
of the proforma, 21 patients met the inclusion criteria, of these, 18 (85.6%)
patients had appropriate outcomes and 3 patients (14.35) had inappro-
priate outcomes.
Conclusions: The introduction of a proforma with speciﬁc criteria for
admission has caused a reduction in unnecessary bed-days and improved
patient safety by reducing the number of inappropriate discharges.
0125: RAISED PSA: IS THE PROSTATE BIG, BAD, OR BOTH?
Dafydd Loughran *. Wrexham Maelor Hospital, Wales, UK.
Abstracts / International Journal of Surgery 12 (2014) S13eS117S102Introduction: This paper aims to expand on Partin’s previous work by
analysing the impact of radiological stage, Gleason scoring and percentage
involvement seen in biopsy tissue, upon PSA scoring.
Methods: Data was collected retrospectively from a cohort of proven
prostate cancer patients in North Wales diagnosed between October 2012
& October 2013. From 236 patients, ninety-eight had undergone the full
staging investigations required for analysis.
Results: Results showed that PSA levels do not show predictable correla-
tion with tumour severity across each prognostic measure. Increase in PSA
from T0 to T2 tumours was not statistically signiﬁcant, and was weakly
signiﬁcant when comparing T2 to T3 tumours (p<0.1). No statistical sig-
niﬁcance was seen when comparing PSA results from 1st, 2nd, or total
Gleason scores. Although not statistically signiﬁcant, the trend shows
increasing PSA levels in patients with total Gleason scores from 6 to 8,
before a steep decline at 9& 10. Statistically signiﬁcant PSA rises were seen
with increasing tumour cell inﬁltration percentages when analysing both
average involvement across bilateral biopsy cores (p<0.05) and maximum
involvement in single cores (p<0.05).
Conclusions: In conclusion the percentage of tumour inﬁltration in any
volume of tissue appears to be the most signiﬁcant factor inﬂuencing PSA
levels.
0126: COOK RESONANCE METALLIC URETERIC STENT: CONTEMPORARY
CLINICAL SERIES ASSESSING FEASIBILITY, SAFETY AND EFFICACY
Dafydd Loughran *, Mohamed Abdulmajed, Rachel Jones,
Pallavoor Anandaram, Iqbal Shergill. Wrexham Maelor Hospital, Wales, UK.
Introduction: The Cook resonance metallic ureteric stent has been used as
an alternative method to treat upper urinary tract obstruction. In this
paper we assess the feasibility, safety and efﬁcacy of this procedure.
Methods: Clinical experience at our institution, between April 2010 and
October 2013 was critically assessed, in terms of patient demographics,
clinical indication, length of operative procedure, radiation exposure and
duration, as well as immediate and late complications.
Results: Overall, 39 Cook Resonance metallic ureteric stent insertions
(stent units) were placed in 17 patients over the 3 year study period
(Median age 62 years; range 45-90). Indications for stent insertion was
retroperitoneal ﬁbrosis (n¼17), malignancy (n¼11), and benign disease
(n¼11). Procedures were successful in all but one case, which required
antegrade approach, due to migrated stent. Median duration of surgery
was 28 mins (Range 12-90). Median radiation exposure was 764CGycm2
with an average X-Ray time of 3:22. Urosepsis occurred in 1 patient, and
late complication occurred in only one case, resulting in hydronephrosis
and was managed with nephrostomy insertion. Stent could not be toler-
ated in 2 stent units due to pain.
Conclusions: We have demonstrated that Cook resonance metallic stent
insertion is feasible, safe and efﬁcacious in cases of upper urinary tract
obstruction.
0130: HOW THE WORLDWIDE SHORTAGE OF BCG (IMMUCYST)
AFFECTED THE MANAGEMENT OF HIGH-RISK, NON-MUSCLE INVASIVE
BLADDER CANCER IN A DISTRICT GENERAL HOSPITAL
Matthew Hillen *, Alex Rawlinson, Amy Slater, Caroline Coull, Ian Mitchell.
Victoria Hospital, NHS Fife, Kirkcaldy, UK.
Introduction: This study investigated the recurrence rates of bladder
cancer in those receiving BCG (ImmuCyst) prior to the shortage, how
patients' management was affected during the shortage and the
recurrence rates when an alternative type of BCG (OncoTICE) was
introduced.
Methods: The study included 53 patients who received ImmuCyst be-
tween 2008-11, 40 patients whose management was affected by the
shortage in 2012 and 39 patients who are currently being treated with
OncoTICE. Data was collected retrospectively from patients' BCG treatment
regime records, pathology reports and clinic letters.
Results: 38/53 (72%) of those receiving ImmuCyst developed recurrence
from 2008-11. Of these 38 patients, 26 (68%) only received induction
therapy. During the shortage, 40 patients were receiving ImmuCyst and 3
were newly diagnosed. 5/40 (12.5%) developed recurrence and were put
on surveillance. 7/39 (18%) of those currently receiving OncoTICE have
developed recurrence.
Conclusions: This study has shown that the BCG shortage did not signif-
icantly affect the management of our patients and has actually led topatients being treated with a clinically observed better-tolerated BCG
therapy. It has been observed from the small numbers accrued so far that
OncoTICE is associated with a lower recurrence rate.
0145: COMPARISON OF OFF-CLAMP PARTIAL NEPHRECTOMY AND ON-
CLAMP PARTIAL NEPHRECTOMY: A SYSTEMATIC REVIEW AND META-
ANALYSIS
Abhishek Trehan *. University of Oxford, Oxford, UK.
Introduction: To compare peri-operative and post-operative variables,
surgical complications, oncological outcomes and renal outcomes of off-
clamp partial nephrectomy and on-clamp partial nephrectomy.
Methods: A systematic search of the electronic databases, including
MEDLINE, Embase and The Cochrane Library. The pooled estimates of
tumour size, operative time, estimated blood loss, length of stay, overall
complications, transfusion rates, urinary leaks, positive surgical margins
and eGFR were calculated.
Results: Fourteen studies were included. There was no signiﬁcant differ-
ence between off-clamp partial nephrectomy and on-clamp partial ne-
phrectomy in terms of tumour size, operative time, estimated blood loss,
length of stay, overall complications, transfusion rates, urinary leaks,
positive surgical margins. Off-clamp partial nephrectomy was associated
with a signiﬁcantly lower reduction in eGFR than on-clamp partial ne-
phrectomy (standardised weighted mean difference (SWMD) ¼ 0.27, 95%
CI: 0.14e0.40, P < 0.0001).
Conclusions: Off-clamp partial nephrectomy may be associated with
improved long-term renal outcomes when compared to on-clamp partial
nephrectomy with no difference in peri-operative and post-operative
variables, surgical complications and oncological outcomes. However, the
meta-analysis was limited by the design of the underlying studies, and
hence further work is needed in order to deﬁnitively establish whether off-
clamp partial nephrectomy confers any advantage over on-clamp partial
nephrectomy.
0148: THE ROLE OF CULTURAL BACKGROUND ON ATTITUDES AND MAN-
AGEMENT OF LOWER URINARY TRACT SYMPTOMS: A COMPARATIVE
STUDY BETWEEN UGANDA AND THE UNITED KINGDOM
Alison Bing *,1, Aakash Pai 1, Blair Tweedie 1, Adam Jones 1, James N'Dow1,
Francis Banya 1. 1Kisiizi Hospital, Kabale, Uganda.
Introduction: Between Uganda and the UK: Establish the severity of lower
urinary tract symptoms (LUTS). Compare attitudes towards LUTS. Compare
management of LUTS.
Methods: Prospective data collection from 80 men aged 45-85 from a
Ugandan hospital and 80 men from two UK hospitals using the Interna-
tional Prostate Symptoms Score (IPSS) survey along with a socio-de-
mographic questionnaire. Data collected on age, medications, education
level, occupation and distance travelled to hospital. Exclusion criteria:
urological presenting complaint, catheter, urinary tract infection, neuro-
pathic bladder, prostatectomy.
Results: There was no difference in age or severity of LUTS
(p¼0.9741) between the two groups. No Ugandan subjects received
medical management for LUTS compared to 18% of UK participants.
87% of UK men with severe LUTS (IPSS 20-35) had a more severe
Quality of Life score of 4-6, which was signiﬁcantly higher than the
Ugandan group (60%) (p¼0.0476). In patients with worse LUTS, no
Ugandan men received medical management compared to 39% of UK
men.
Conclusions: Cultural background and expectations play an important
role in the management of LUTS, highlighting the importance of the pa-
tient's perception of symptoms. In addition, the contrasting access to
urological services between Uganda and the UK is demonstrated.
0211: IS THE DAYCASE TURBT A REALISTIC POSSIBILITY IN THE DISTRICT
HOSPITAL SETTING?
K.A. Bailey, T.E.M. Morrison *, M. Hilmy, S.C. Hagyard. York Hospital NHS
Trust, York, UK.
Introduction: 10,000 people are diagnosed with bladder cancer annually.
A TURBT (transurethral resection of bladder tumour) is the mainstay of
treatment. With greater demands on theatre time and an increasing drive
to theatre efﬁciency we wanted to evaluate the possibly of the day case
TURBT in our District Hospital. Nationally only 19.1% of TURBT's are per-
formed as a day case against a 40% target.
